Cargando…

Seasonal coronaviruses and SARS-CoV-2: effects of preexisting immunity during the COVID-19 pandemic

Although the coronavirus disease 2019 (COVID-19) epidemic is still ongoing, vaccination rates are rising slowly and related treatments and drugs are being developed. At the same time, there is increasing evidence of preexisting immunity against severe acute respiratory syndrome coronavirus 2 (SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, Gang, XIANG, Ze, WANG, Wei, CHEN, Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Zhejiang University Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198228/ https://www.ncbi.nlm.nih.gov/pubmed/35686525 http://dx.doi.org/10.1631/jzus.B2200049

Ejemplares similares

Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France
por: Zedan, Hadeel T., et al.
Publicado: (2021)

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
por: Ng, Kevin W., et al.
Publicado: (2020)

A pangolin-origin SARS-CoV-2-related coronavirus: infectivity, pathogenicity, and cross-protection by preexisting immunity
por: Huang, Xing-Yao, et al.
Publicado: (2023)

Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity
por: Alefishat, Eman, et al.
Publicado: (2022)

No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults
por: Ercanoglu, Meryem Seda, et al.
Publicado: (2022)

Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections
por: Selva, Kevin J., et al.
Publicado: (2023)

Do preexisting antibodies against seasonal coronaviruses have a protective role against SARS-CoV-2 infections and impact on COVID-19 severity?
por: Nasrallah, Gheyath K.
Publicado: (2022)

Effect of preexisting infection-induced immunity on neonatal and maternal outcomes of SARS-CoV-2 infection in pregnancy
por: Berry, Marissa J., et al.
Publicado: (2023)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
por: Lee, Eun-Ju, et al.
Publicado: (2022)

Will SARS-CoV-2 Become Just Another Seasonal Coronavirus?
por: Beams, Alexander B., et al.
Publicado: (2021)

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France
por: Woudenberg, Tom, et al.
Publicado: (2021)

How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology
por: Waterlow, Naomi R., et al.
Publicado: (2021)

Preexisting conditions among the SARS-CoV2 deaths during the SARS-CoV2 B.1.617.2 (Delta variant) outbreak in the United Kingdom
por: Emani, Venkata R., et al.
Publicado: (2022)

Bioinformatic HLA Studies in the Context of SARS-CoV-2 Pandemic and Review on Association of HLA Alleles with Preexisting Medical Conditions
por: Mobini Kesheh, Mina, et al.
Publicado: (2021)

Individual Immune Response to SARS-CoV-2 Infection—The Role of Seasonal Coronaviruses and Human Leukocyte Antigen
por: Rottmayer, Karla, et al.
Publicado: (2023)

A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2
por: Majdoubi, Abdelilah, et al.
Publicado: (2021)

SARS-Coronavirus (SARS-CoV)
por: Kehm, Roland
Publicado: (2009)

Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
por: Yao, Zhixian, et al.
Publicado: (2020)

Humoral response to SARS‐CoV‐2 and seasonal coronaviruses in COVID‐19 patients
por: Adams, Ortwin, et al.
Publicado: (2021)

Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity
por: Jia, Liqiu, et al.
Publicado: (2022)

Preexisting Humoral Immunity Cross-Reacting with SARS-CoV-2 Might Prevent Death Due to COVID-19 in Critical Patients
por: Yamashita, Taro, et al.
Publicado: (2022)

Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic
por: Singh, Shalinder, et al.
Publicado: (2020)

The immune system view of the coronavirus SARS-CoV-2
por: Celardo, Ivana, et al.
Publicado: (2020)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses
por: Kirtipal, Nikhil, et al.
Publicado: (2020)

Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection
por: Poston, Daniel, et al.
Publicado: (2020)

Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies
por: Wong, Lydia Su Yin, et al.
Publicado: (2023)

Differential T cell reactivity to seasonal coronaviruses and SARS-CoV-2 in community and health care workers
por: da Silva Antunes, Ricardo, et al.
Publicado: (2021)

Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses
por: Wratil, Paul R., et al.
Publicado: (2021)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2
por: Zhu, James, et al.
Publicado: (2020)

Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice
por: Ordonez, Alvaro A., et al.
Publicado: (2022)

Mind the feline coronavirus: Comparison with SARS-CoV-2
por: Gao, Yong-yu, et al.
Publicado: (2022)

Accessory proteins of SARS-CoV and other coronaviruses
por: Liu, Ding Xiang, et al.
Publicado: (2014)

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
por: Dong, Yetian, et al.
Publicado: (2020)

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
por: Loos, Carolin, et al.
Publicado: (2020)

Anti-SARS-CoV-2 IgM Secondary Response Was Suppressed by Preexisting Immunity in Vaccinees: A Prospective, Longitudinal Cohort Study over 456 Days
por: Xu, Qiu-Yan, et al.
Publicado: (2023)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q6cgrksssl6juuj3sb967v5c4q